Status:
COMPLETED
Follow-up Study After Bankart Repair Using MG-1
Lead Sponsor:
Johnson & Johnson K.K. Medical Company
Conditions:
Shoulder Dislocation
Eligibility:
All Genders
16+ years
Brief Summary
Long term follow-up of patients those who underwent arthroscopic Bankart repair using MG-1 for dislocation of shoulder to evaluate anchor bone hole condition and ossification.
Eligibility Criteria
Inclusion
- Patient who was enrolled to the clinical trial of MG-1 at Funabashi Orthopaedic Hospital and who don't withdraw the consent
- Patient who understand the contents of the study and from whom a written consent can be obtained
Exclusion
- Patient with dementia
- Patient who cannot undergo CT examination
- Patient who underwent further surgery to ipsilateral shoulder joint after the clinical trial
- Patient who is pregnant or lactating
- Patient judged to be inappropriate for the study by the (sub)investigator
Key Trial Info
Start Date :
August 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2015
Estimated Enrollment :
11 Patients enrolled
Trial Details
Trial ID
NCT02228226
Start Date
August 1 2014
End Date
April 1 2015
Last Update
April 16 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Funabashi Orthopaedic Hospital
Funabashi, Chiba, Japan